OBJECTIVE: This study was designed to investigate the effects of long term clozapine
treatment on changes of weight, glucose and cholesterol levels and their relation to …

Object: The goal of this study was to examine the changes in body weight and glucose
levels of the patients treated with risperidone, clozapine or haloperidol in order to compare …

Background Metabolic syndrome is an important side effect associated with clozapine. It has
been hypothesized that weight gain contributes to the development of metabolic syndrome …

Method: This study is a retrospective cohort study combining a cross-sectional survey of
metabolic syndrome and retrospective chart review. The subjects were hospitalized …

OBJECTIVE: Clozapine is associated with significant weight gain. However, it is still
debatable whether the majority of weight gain occurs in the early phase of treatment or if …

OBJECTIVE: The purpose of this study is to assess the effect of risperidone, olanzapine,
quetiapine, amisulpride on glucose, lipid levels and body weight changes in Korean patients …

OBJECTIVE: The concerns about significant weight gain induced by antipsychotics have
been recently increased. It raised an issue about the possible effect of antipsychotics on the …

We examined the effects of long-term clozapine treatment, concurrent treatment with β-
adrenergic antagonists, and clozapine-induced weight gain on serum glucose and lipid …

Objective: The aim of this study was to test whether the initial antipsychotic response to
clozapine is related to subsequent weight change. Method: This study was an 8-year …

Background: Both obesity and smoking are common in schizophrenia patients taking
clozapine, causing cardiovascular disease and premature deaths. Methods: Two hundred …